1. Poinar G. Plasmodium dominicana n. sp. (Plasmodiidae: Haemospororida) from Tertiary Dominican amber. Syst. Parasitol. 2005; 561 (1): 47–52.
2. Conner, Clifford D. (2005). A People's History of Science: Miners, Midwives, and 'Low Mechanicks'. New York: Nation Books. pp. 95–96.
3. Vernick KD, Oduol F, Lazarro BP, Glazebrook J, Xu J, Riehle M, Li J. "Molecular Genetics of Mosquito Resistance to Malaria Parasites". In Sullivan, D; Krishna, S. (eds.). Malaria: Drugs, Disease, and Post-genomic Biology. 2005; Springer. p. 384.
4. Antinori S, Galimberti L, Milazzo L, Corbellino M. Plasmodium knowlesi: the emerging zoonotic parasite. Acta Trop. 2013; 125:191–201.
5. Rajahram GS, Barber BE, William T, Menon J, Anstey NM, Yeo TW. Deaths due to Plasmodium knowlesi malaria in Sabah, Malaysia: association with reporting as Plasmodium malariae and delayed parenteral artesunate. Malar J. 2012; 11:284. doi: 10.1186/1475-2875-11-284.
6. Yusof R, Lau YL, Mahmud R, Fong MY, Jelip J, Ngian HU, et al. High proportion of knowlesi malaria in recent malaria cases in Malaysia. Malar J. 2014; 13:168. doi: 10.1186/1475-2875-13-168.
7. Posfai D, Sylvester K, Reddy A, Ganley JG, Wirth J, Cullen Q et al, Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infection, PLOS Pathogens. 2018. DOI: 10.1371/journal.ppat.1007057
8. Claire L, Mackintosh, James G, Beeson Kevin Marsh. Clinical features and pathogenesis of severe malaria. TRENDS in Parasitology. 2004; 20(12).
9. Rowe JA, Claessens A, Corrigan RA, Arman M. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert reviews in molecular medicine. 2009; Vol. 11; e16.
10. Goncalves BP, Huang CY, Morrison R, Holte S, Kabyemela E, Prevots DR, et al. Parasite burden and severity of malaria in Tanzanian children. N Engl J Med. 2014; 370:1799–1808.
11. Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010; 68(4):267-74.
12. Ojezele MO, Moke EG, Onyesom I. Impact of generic antimalarial or Phyllanthus amarus and vitamin co-administration on antioxidant status of experimental mice infested with Plasmodium berghei. Beni-Suef University Journal of Basic and Applied Sciences. 2017; (6): 3: 260-265.
13. Basir R, Fazalul-Rahiman SS, Hasballah K, Chong WC, Talib H, Yam MF, et al. Plasmodium berghei ANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iranian J Parasitol. 2012; 7(4):62-74.
14. Centers for Disease Control and Prevention's. “Malaria diagnosis (United States)” 2015. Retrieved on the 24th of May, 2019 http:www.cdc.gov/malaria/diagnosis_treatment/diagnosis.html
15. Anand AC, Ramji C, Narula AS, and Singh W. Malarial hepatitis: a heterogeneous syndrome. Natl Med J India. 1992; 5:59-62.
16. Anand A, and Puri P. Jaundice in malaria. J Gastroenterol Hepatol. 2005; 20: 1322-1332.
17. Dey S, Guha M, Alam A, Goyal M, Bindu S, Pal C, et al. Malarial infection develops mitochondrial pathology and mitochondrial oxidative stress to promote hepatocyte apoptosis. Free Radic Biol Med. 2009; 46: 271-281.
18. Klotz C, and Frevert U. Plasmodium yoelii sporozoites modulate cytokine profile and induce apoptosis in murine Kupffer cells. Int J Parasitol. 2008; 38: 1639-1650.
19. Rupani AB, and Amarapurkar AD. Hepatic changes in fatal malaria: an emerging problem. Ann Trop Med Parasitol. 2009; 103: 119-127.
20. Whitten R, Milner DA, Yeh MM, Kamiza S, Molyneux ME, Taylor TE. Liver pathology in Malawian children with fatal encephalopathy. Hum Pathol. 2011; 42: 1230-1239.
21. Joshi YK, Tandon BN, Acharya SK, Babu S, Tandon M. Acute hepatic failure due to Plasmodium falciparum liver injury. Liver. 1986; 6: 357-360.
22. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol. 2006; 12(46):7413-20.
23. Viriyavejakul P, Khachonsaksumet V, Punsawad C. Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression. Malar J. 2014; 13:106.
24. Anusha MG, and Nirbhay Kumar. Antimalarial Action of Artesunate Involves DNA Damage Mediated by Reactive Oxygen Species. Antimicrobial Agents Chemotherapy. 2015; 59(1): 317-325.
25. Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, von Seidlein L. Artemisinin resistance: Current status and scenarios for containment. Nature Reviews Microbiology. 2010; 8(4): 272–280.
26. Richard I., Kevin M., Chandy C. and Charles R. Cerebral Malaria, Mechanisms of Brain Injury and Strategies for Improved Neuro-Cognitive Outcome. Pediatr Res. 2010; 68(4): 267–274.
27. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 1985; 119, 385–401.
28. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, et al. The neuropathology of fatal cerebral malaria in malawian children. Am. J. Pathol. 2011; 178: 2146–2158.
29. Jennings VM, Actor JK, Lal AA, Hunter RL. Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect Immun. 1997; 65:4883-4887.
30. Hearn J, Rayment N, Landon DN, Katz DR, de Souza JB. Immunopathology of Cerebral Malaria: Morphological Evidence of Parasite Sequestration in Murine Brain Microvasculature. Infect Immun. 2000; 68:5364-5376.